Pulmozyme and Eating disorder - a phase IV clinical study of FDA data

Summary:

Eating disorder is reported as a side effect among people who take Pulmozyme (dornase alfa), especially for people who are female, 30-39 old, also take Trikafta, and have Pseudomonas infection.

The phase IV clinical study analyzes which people have Eating disorder when taking Pulmozyme. It is created by eHealthMe based on reports of 19,995 people who have side effects when taking Pulmozyme from the FDA, and is updated regularly.

What is Pulmozyme?

Pulmozyme has active ingredients of dornase alfa. It is often used in cystic fibrosis. eHealthMe is studying from 20,012 Pulmozyme users. Check the latest studies of Pulmozyme.

What is Eating disorder?

Eating disorder is found to be associated with 1,368 drugs and 1,442 conditions by eHealthMe. Check the latest studies of Eating disorder.

On Jul, 14, 2026

19,995 people reported to have side effects when taking Pulmozyme.
Among them, 22 people (0.11%) have Eating disorder.

Among these 22 people:

What is the gender of people who have Eating disorder when taking Pulmozyme? *

female: 77.27 %
male: 22.73 %

What is the age of people who have Eating disorder when taking Pulmozyme? *

What are other drugs people take besides Pulmozyme? *

What are other side effects people have besides Eating disorder? *

Weight Decreased: 8 people, 36.36%
Stress And Anxiety: 7 people, 31.82%
Cough: 6 people, 27.27%
Nausea (feeling of having an urge to vomit): 6 people, 27.27%
Appetite - Decreased (decreased appetite occurs when you have a reduced desire to eat): 5 people, 22.73%
Insomnia (sleeplessness): 5 people, 22.73%
Nausea And Vomiting: 4 people, 18.18%
Depression: 4 people, 18.18%
Consciousness - Decreased: 4 people, 18.18%
Gastroenteritis Viral (inflammation of stomach and intestine caused by virus infection): 4 people, 18.18%

What are the existing conditions these people have? *

Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 3 people, 13.64%

* Approximation only. Some reports may have incomplete information.

Do you take Pulmozyme and have Eating disorder?

- Check whether Eating disorder is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Pulmozyme:

Pulmozyme (20,012 reports)

Eating disorder treatments and more:

Eating disorder (27,588 reports)

Browse all side effects of Pulmozyme:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Eating disorder:

Eating disorder (1,368 drugs)

Browse all the conditions that are associated with Eating disorder:

Eating disorder (1,442 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on dornase alfa (the active ingredients of Pulmozyme) and Pulmozyme (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.